Archives
Risk Factors for Rapid Disease Progression of ADPKD
About This Event
Risk Factors for Rapid Disease Progression of ADPKD
In this presentation rapid disease progression of autosomal dominant polycystic kidney disease (ADPKD) will be defined. The risk factors that assist in determining if a patient is at risk of rapid disease progression will be discussed.
Cypress by the Revenir
Shreveport, Louisiana 71106 United States + Google Map
Featuring
Frederic Rahbari, MD, MS*
Emory University*
Dr. Frederic Rahbari is the director of Cystic Kidney Diseases Clinic at Emory University and has been a nephrologist practicing at Emory University Hospital in Atlanta, GA since 2006. Dr. Rahbari attended medical school at Université de Bordeaux in France and completed a residency program at the same institution. After moving to the US, Dr. Rahbari did clinical and translational research on oxidative stress at New York Medical College and subsequently redid three years of residency training in internal medicine at St. Vincent Hospital -Columbia University College of Physicians and Surgeons. He has also completed a fellowship in nephrology at Emory University. Dr. Rahbari has been a principal investigator in several PKD trials and is a member of the Scientific Advisory Committee of the Polycystic Kidney Disease Foundation.
Hannah N. Lambert, PharmD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Hannah N. Lambert is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.
Speakers are either paid consultants or employees of Otsuka Pharmaceutical Development and Commercialization Inc.
